Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | LAP3 | P28838 | 10/20 | 0.38 |
| ▸ | ANPEP | P15144 | 7/20 | 0.38 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.35 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.34 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.34 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.31 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3720254 | 0.79 | SLC7A5 (0.48) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| SCHEMBL28734812 | 0.75 | SLC7A5 (0.44) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| SCHEMBL28734807 | 0.72 | SLC7A5 (0.41) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| SCHEMBL9100153 | 0.72 | SLC7A5 (0.58) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| SCHEMBL16049321 | 0.72 | SLC7A5 (0.58) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| SCHEMBL995721 | 0.72 | SLC7A5 (0.58) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| Phosphoric Acid SCHEMBL28734814 | 0.72 | SLC7A5 (0.48) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| Phosphoric Acid SCHEMBL28734810 | 0.70 | SLC7A5 (0.47) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| SCHEMBL24798069 | 0.70 | SLC7A5 (0.56) | SLC7A5LAP3ANPEPERAP1SLC1A3 | |
| SCHEMBL12345872 | 0.70 | SLC7A5 (0.56) | SLC7A5LAP3ANPEPERAP1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11779012-B2 | Compositions and methods for preserving red blood cells and platelets | RYTHRX THERAPEUTICS, LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-20220248666-A1 | COMPOSITIONS AND METHODS FOR PRESERVING RED BLOOD CELLS AND PLATELETS | RYTHRX THERAPEUTICS, LLC | 2022-08-11 | — | — | US | disclosed |
| US-11344026-B2 | Compositions and methods for preserving red blood cells and platelets | RYTHRX THERAPEUTICS, LLC (US) | 2022-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11344026-B2 | Compositions and methods for preserving red blood cells and platelets | RCN1, THPO, TYMP | SLC7A5 4176/4885LAP3 4661/4885ANPEP 2635/4885 |
| US-11779012-B2 | Compositions and methods for preserving red blood cells and platelets | RCN1, THPO, TYMP | SLC7A5 4176/4885LAP3 4661/4885ANPEP 2635/4885 |
| US-20220248666-A1 | COMPOSITIONS AND METHODS FOR PRESERVING RED BLOOD CELLS AND PLATELETS | RCN1, THPO, TYMP | SLC7A5 4176/4885LAP3 4661/4885ANPEP 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.